+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sickle Cell Drug"

From
From
Sickle Cell Disease Treatment Market Report 2025 - Product Thumbnail Image

Sickle Cell Disease Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Sickle Cell Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Sickle Cell Disease - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 180 Pages
  • Global
From
From
From
Hemoglobinopathies - Global Strategic Business Report - Product Thumbnail Image

Hemoglobinopathies - Global Strategic Business Report

  • Report
  • March 2025
  • 192 Pages
  • Global
From
Anemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Anemia Drugs - Global Strategic Business Report

  • Report
  • February 2025
  • 383 Pages
  • Global
From
From
Sickle Cell Disease - Epidemiology Forecast - 2034 - Product Thumbnail Image

Sickle Cell Disease - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 99 Pages
  • Global
From
From
From
Latin America Hemoglobinopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Latin America Hemoglobinopathies Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Latin America
From
North America Hemoglobinopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

North America Hemoglobinopathies Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 120 Pages
  • North America
From
Loading Indicator

The Sickle Cell Drug market is a subset of the larger Hematological Drugs market. It is composed of drugs used to treat sickle cell disease, a genetic disorder that affects red blood cells. These drugs are used to reduce the frequency of painful episodes, reduce the risk of organ damage, and improve the quality of life for those affected. Common treatments include hydroxyurea, which helps to reduce the number of sickle cells in the blood, and L-glutamine, which helps to reduce the risk of organ damage. Other treatments include blood transfusions, stem cell transplants, and gene therapy. Companies in the Sickle Cell Drug market include Novartis, GlaxoSmithKline, Pfizer, Sanofi, and Merck. Show Less Read more